292 related articles for article (PubMed ID: 10206305)
21. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
Wiernikowski JT; Barr RD; Webber C; Guo CY; Wright M; Atkinson SA
J Oncol Pharm Pract; 2005 Jun; 11(2):51-6. PubMed ID: 16460605
[TBL] [Abstract][Full Text] [Related]
22. Bone mineral density in long-term survivors of childhood cancer.
Hesseling PB; Hough SF; Nel ED; van Riet FA; Beneke T; Wessels G
Int J Cancer Suppl; 1998; 11():44-7. PubMed ID: 9876477
[TBL] [Abstract][Full Text] [Related]
23. Effect of long-term growth hormone treatment on bone mass and bone metabolism in growth hormone-deficient men.
Bravenboer N; Holzmann PJ; ter Maaten JC; Stuurman LM; Roos JC; Lips P
J Bone Miner Res; 2005 Oct; 20(10):1778-84. PubMed ID: 16160735
[TBL] [Abstract][Full Text] [Related]
24. Effects of growth hormone therapy on bone mass, metabolic balance, and well-being in young adult survivors of childhood acute lymphoblastic leukemia.
van den Heijkant S; Hoorweg-Nijman G; Huisman J; Drent M; van der Pal H; Kaspers GJ; Delemarre-van de Waal H
J Pediatr Hematol Oncol; 2011 Aug; 33(6):e231-8. PubMed ID: 21792029
[TBL] [Abstract][Full Text] [Related]
25. Consequences of childhood-onset growth hormone deficiency for adult bone mass.
de Boer H; Blok GJ; van Lingen A; Teule GJ; Lips P; van der Veen EA
J Bone Miner Res; 1994 Aug; 9(8):1319-26. PubMed ID: 7976513
[TBL] [Abstract][Full Text] [Related]
26. Bone mass and body composition after cessation of therapy for childhood cancer.
Nysom K; Mølgaard C; Holm K; Hertz H; Michaelsen KF
Int J Cancer Suppl; 1998; 11():40-3. PubMed ID: 9876476
[TBL] [Abstract][Full Text] [Related]
27. [Bone mass in patients with cystic fibrosis of the pancreas. Relationship with anthropometric parameters and genotype].
Yeste D; Liñán S; Cobos N; Gussinyé M; del Río L; Carrascosa A
Med Clin (Barc); 1998 Oct; 111(13):485-8. PubMed ID: 9859064
[TBL] [Abstract][Full Text] [Related]
28. Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia.
Hoorweg-Nijman JJ; Kardos G; Roos JC; van Dijk HJ; Netelenbos C; Popp-Snijders C; de Ridder CM; Delemarre-van de Waal HA
Clin Endocrinol (Oxf); 1999 Feb; 50(2):237-44. PubMed ID: 10396368
[TBL] [Abstract][Full Text] [Related]
29. BMD is reduced in HIV-infected men irrespective of treatment.
Amiel C; Ostertag A; Slama L; Baudoin C; N'Guyen T; Lajeunie E; Neit-Ngeilh L; Rozenbaum W; De Vernejoul MC
J Bone Miner Res; 2004 Mar; 19(3):402-9. PubMed ID: 15040828
[TBL] [Abstract][Full Text] [Related]
30. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia.
Gunes AM; Can E; Saglam H; Ilçöl YO; Baytan B
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e102-7. PubMed ID: 20216235
[TBL] [Abstract][Full Text] [Related]
31. Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adults with growth hormone deficiency.
Thorén M; Soop M; Degerblad M; Sääf M
Acta Endocrinol (Copenh); 1993 Jun; 128 Suppl 2():41-3. PubMed ID: 8342392
[TBL] [Abstract][Full Text] [Related]
32. Bone health in children and adolescents after renal transplantation.
Valta H; Mäkitie O; Rönnholm K; Jalanko H
J Bone Miner Res; 2009 Oct; 24(10):1699-708. PubMed ID: 19419296
[TBL] [Abstract][Full Text] [Related]
33. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition.
Atkinson SA; Halton JM; Bradley C; Wu B; Barr RD
Int J Cancer Suppl; 1998; 11():35-9. PubMed ID: 9876475
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone.
Duan Y; De Luca V; Seeman E
J Clin Endocrinol Metab; 1999 Feb; 84(2):718-22. PubMed ID: 10022443
[TBL] [Abstract][Full Text] [Related]
35. Short-term effect of testosterone treatment on reduced bone density in boys with constitutional delay of puberty.
Bertelloni S; Baroncelli GI; Battini R; Perri G; Saggese G
J Bone Miner Res; 1995 Oct; 10(10):1488-95. PubMed ID: 8686504
[TBL] [Abstract][Full Text] [Related]
36. Reduced bone mineral density in patients with adult onset growth hormone deficiency.
Holmes SJ; Economou G; Whitehouse RW; Adams JE; Shalet SM
J Clin Endocrinol Metab; 1994 Mar; 78(3):669-74. PubMed ID: 8126140
[TBL] [Abstract][Full Text] [Related]
37. Thin healthy women have a similar low bone mass to women with anorexia nervosa.
Fernández-García D; Rodríguez M; García Alemán J; García-Almeida JM; Picón MJ; Fernández-Aranda F; Tinahones FJ
Br J Nutr; 2009 Sep; 102(5):709-14. PubMed ID: 19302720
[TBL] [Abstract][Full Text] [Related]
38. Bone turnover markers and bone mineral density in children with haemophilia.
Tlacuilo-Parra A; Villela-Rodríguez J; Garibaldi-Covarrubias R; Soto-Padilla J; Orozco-Alcala J
Haemophilia; 2011 Jul; 17(4):657-61. PubMed ID: 21118337
[TBL] [Abstract][Full Text] [Related]
39. [Bone mineral density and markers of bone turnover in patients treated for malignant disease in childhood].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M; Łuczyński W; Kaczmarski M; Wołczynski S; Piotrowska-Jastrzebska J
Med Wieku Rozwoj; 2004; 8(4 Pt 2):1041-54. PubMed ID: 15951599
[TBL] [Abstract][Full Text] [Related]
40. Turner syndrome and osteoporosis: mechanisms and prognosis.
Rubin K
Pediatrics; 1998 Aug; 102(2 Pt 3):481-5. PubMed ID: 9685448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
